These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 6232001)

  • 21. Indomethacin therapy abrogates the prostaglandin-mediated suppression of natural killer activity in tumor-bearing mice and prevents tumor metastasis.
    Lala PK; Parhar RS; Singh P
    Cell Immunol; 1986 Apr; 99(1):108-18. PubMed ID: 2944621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Promotion of macrophage-stimulated autoreactive T cell proliferation by interleukin-10: counteraction of macrophage suppressor activity during tumor growth.
    Alleva DG; Elgert KD
    Immunobiology; 1995 Feb; 192(3-4):155-71. PubMed ID: 7782092
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Failure to reject an allografted tumor after elimination of macrophages in mice.
    Ushio Y; Yamamoto N; Sanchez-Bueno A; Yoshida R
    Microbiol Immunol; 1996; 40(7):489-98. PubMed ID: 8865154
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Possible role of macrophage-like suppressor cells in the anti-tumour activity of BCG.
    Castés M; Lynch NR; Lespinats G; Orbach-Arbouys S
    Br J Cancer; 1981 Dec; 44(6):828-37. PubMed ID: 6459797
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dendritic cells are accessory cells for the development of anti-trinitrophenyl cytotoxic T lymphocytes.
    Nussenzweig MC; Steinman RM; Gutchinov B; Cohn ZA
    J Exp Med; 1980 Oct; 152(4):1070-84. PubMed ID: 6968335
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Kinetic analysis of the inhibition of natural killer (NK) activity by multiple populations of tumor-activated suppressor cells.
    Johnson DR; Pope BL
    Immunobiology; 1986 Apr; 171(3):205-19. PubMed ID: 2872155
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of murine tumors upon delayed hypersensitivity to dinitrochlorobenzene. III. In vivo activity of the nonspecific suppressor cell.
    Jessup JM; Macek CM; Kahan BD; Pellis NR
    J Immunol; 1981 Nov; 127(5):2183-7. PubMed ID: 6457866
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Shifts in macrophage (M phi) surface phenotypes during tumor growth: association of Mac-2+ and Mac-3+ M phi with immunosuppressive activity.
    Garner RE; Malick AP; Yurochko AD; Elgert KD
    Cell Immunol; 1987 Sep; 108(2):255-68. PubMed ID: 2957065
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Selectively eliminated blood monocytes and splenic suppressor macrophages in mice depleted of bone marrow by strontium 89.
    Shibata Y; Dempsey WL; Morahan PS; Volkman A
    J Leukoc Biol; 1985 Dec; 38(6):659-69. PubMed ID: 3864908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancement of T cell MLR reactivity by addition of macrophage supernatants from tumor-bearing mice.
    Elgert KD; Connolly KM
    Oncology; 1980; 37(2):101-6. PubMed ID: 6444706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of spontaneous and mitogen-induced lymphocyte proliferation by murine bone marrow-derived macrophages: role of prostaglandins, nitric oxides and cell-to-cell contact.
    Zwadlo-Klarwasser G; Platen S; Schmutzler W
    Scand J Immunol; 1994 Jul; 40(1):10-5. PubMed ID: 8029637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Production of colony-stimulating factor by tumor cells and the factor-mediated induction of suppressor cells.
    Tsuchiya Y; Igarashi M; Suzuki R; Kumagai K
    J Immunol; 1988 Jul; 141(2):699-708. PubMed ID: 2968407
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumour-induced suppressor macrophages in rats: differences in their suppressive effects on the Con A and PHA responses.
    Mizushima Y; Wepsic HT; Yamamura Y; Desilva MA
    Clin Exp Immunol; 1984 Aug; 57(2):371-9. PubMed ID: 6235988
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Requirement for prostaglandin E1 (PGE1) for the secretion of suppressor cell inducer factors by spleen cells of tumor-bearing mice.
    Pillay DJ; Pope BL
    Int J Immunopharmacol; 1986; 8(2):221-6. PubMed ID: 2940192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activation of suppressor T cells by low-molecular-weight factors secreted by spleen cells from tumor-bearing mice.
    Pope BL
    Cell Immunol; 1985 Jul; 93(2):364-74. PubMed ID: 2860974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of cytotoxic T lymphocyte development by a minor stimulating locus-induced suppressor cascade that involves Lyt-1+ suppressor T cells, IA- macrophages, and their factors.
    Chow KP; Battisto JR
    J Immunol; 1988 Feb; 140(4):1005-13. PubMed ID: 2963857
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostaglandin E2 production by Mac-2+ macrophages: tumor-induced population shift.
    Malick AP; Elgert KD; Garner RE; Adkinson NF
    J Leukoc Biol; 1987 Dec; 42(6):673-81. PubMed ID: 2960767
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Variations in macrophage antigen phenotype: a correlation between Ia antigen reduction and immune dysfunction during tumor growth.
    Garner RE; Malick AP; Elgert KD
    J Leukoc Biol; 1986 Nov; 40(5):561-74. PubMed ID: 3464674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Splenic macrophages from tumor-bearing mice co-expressing MAC-1 and MAC-2 antigens exert immunoregulatory functions via two distinct mechanisms.
    Watson GA; Fu YX; Lopez DM
    J Leukoc Biol; 1991 Feb; 49(2):126-38. PubMed ID: 1991996
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Studies on the suppressor cells acting on the mitogen-induced blastogenesis in tumor-bearing hosts. I. Suppressor cells in the spleens and peripheral blood of tumor-bearing rats (author's transl)].
    Takami M
    Nihon Seikeigeka Gakkai Zasshi; 1980 Nov; 54(11):1553-62. PubMed ID: 6453174
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.